CD79 alpha/CD79 beta heterodimers are expressed on pro-B cell surfaces without associated mu heavy chain

被引:53
作者
Koyama, M
Ishihara, K
Karasuyama, H
Cordell, JL
Iwamoto, A
Nakamura, T
机构
[1] UNIV TOKYO,INST MED SCI,DEPT INFECT DIS & APPL IMMUNOL,MINATO KU,TOKYO 108,JAPAN
[2] OSAKA UNIV,SCH MED,CTR BIOMED RES,DEPT MOL ONCOL,OSAKA 565,JAPAN
[3] TOKYO METROPOLITAN INST MED SCI,DEPT IMMUNOL,TOKYO 113,JAPAN
[4] UNIV OXFORD,JOHN RADCLIFFE HOSP,DEPT CELLULAR SCI,LRF IMMUNODIAGNOST UNIT,OXFORD OX3 9DU,ENGLAND
关键词
B lymphocytes; B cell differentiation;
D O I
10.1093/intimm/9.11.1767
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
During B cell development, the surface expression of CD79 alpha/CD79 beta heterodimers had been thought to begin in the pre-B cell stage where the heterodimers constitute pre-B cell receptors together with mu heavy and surrogate light chains, Thereafter, in mature B cells, CD79 alpha/CD79 beta associates with surface Ig to form B cell antigen receptors, In this study, we revealed by using newly established mAb that CD79 beta was expressed on the surface of pro-B cells which had not undergone the productive Ig gene rearrangement, Biochemical analysis showed that CD79 beta on pro-B cells existed either as monomers or as disulfide-linked heterodimers with CD79 alpha, noncovalently associated with four unidentified membrane molecules. Our finding that CD79 beta is expressed on earlier B-lineage cells than previously expected coincides with the recent study in which CD79 beta-deficient mice exhibit a blockade of B cell differentiation at the pro-B cell stage, Thus, it is speculated that the CD79 beta-containing complexes on pro-B cell surfaces may function to induce early B cell differentiation.
引用
收藏
页码:1767 / 1772
页数:6
相关论文
共 16 条
[1]  
FREDERICK WA, 1984, EMBO J, V3, P1209
[2]   Regulation of an early developmental checkpoint in the B cell pathway by Ig beta [J].
Gong, SC ;
Nussenzweig, MC .
SCIENCE, 1996, 272 (5260) :411-414
[3]   RESOLUTION AND CHARACTERIZATION OF PRO-B AND PRE-PRO-B CELL STAGES IN NORMAL MOUSE BONE-MARROW [J].
HARDY, RR ;
CARMACK, CE ;
SHINTON, SA ;
KEMP, JD ;
HAYAKAWA, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1213-1225
[4]   B29 GENE-PRODUCTS COMPLEX WITH IMMUNOGLOBULINS ON LYMPHOCYTES-B [J].
ISHIHARA, K ;
WOOD, WJ ;
DAMORE, M ;
HERMANSON, GG ;
WALL, R ;
KINCADE, PW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) :633-637
[5]   Stage-specific expression of mouse BST-1/BP-3 on the early B and T cell progenitors prior to gene rearrangement of antigen receptor [J].
Ishihara, K ;
Kobune, Y ;
Okuyama, Y ;
Itoh, M ;
Lee, BOK ;
Muraoka, O ;
Hirano, T .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (09) :1395-1404
[6]   A COMPLEX OF GLYCOPROTEINS IS ASSOCIATED WITH V(PREB)/LAMBDA(5) SURROGATE LIGHT-CHAIN ON THE SURFACE OF MU HEAVY CHAIN-NEGATIVE EARLY PRECURSOR B-CELL LINES [J].
KARASUYAMA, H ;
ROLINK, A ;
MELCHERS, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :469-478
[7]   Self-renewal of B-1 lymphocytes is dependent on CD19 [J].
Krop, I ;
deFougerolles, AR ;
Hardy, RR ;
Allison, M ;
Schlissel, MS ;
Fearon, DT .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :238-242
[8]   Fate of surrogate light chains in B lineage cells [J].
Lassoued, K ;
Illges, H ;
Benlagha, K ;
Cooper, MD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :421-429
[9]  
MASON DY, 1991, J IMMUNOL, V147, P2474
[10]  
MATSUO T, 1991, J IMMUNOL, V146, P1584